NCT07691606
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07691606
Title A Study of ARC-02 in B-cell NHL (ABLATE-101)
Acronym ABLATE-101
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | FRA | ESP | AUS


No variant requirements are available.